15 May 2023
ATMP Manufacturing Capabilities Sheet
In 2021 the investment in funding more than 1,200 clinical trials of personalised cell and gene therapies worldwide is an...
14 March 2023
ADC Manufacturing Capabilities Sheet
The development of Antibody-Drug Conjugate (ADC) technologies has facilitated the enhanced targeting of cancer cells with reduced toxic side effects...
9 February 2023
Infographic: Overview of a Qualified Person Release
Under European Union (EU) law, the Qualified Person (QP) is responsible for certifying that each batch of a medicinal product meets...
13 January 2023
Guide: Exporting parenterals to the EU post BREXIT
The UK’s withdrawal from the EU has had an impact on customs procedures, tax and trade, both with the EU...
11 January 2023
Lyophilization Capabilities Sheet
Symbiosis Pharmaceutical Services are a leading provider of lyophilization drug product manufacturing services. We welcome an opportunity to learn about...
6 January 2023
Case Study – Upstream Bio – rapid production of liquid drug product
Upstream Bio are a biotechnology research company based out of Waltham, Massachusetts that is seeking to determine the source of...
12 December 2022
Considerations for choosing a CMO for injectable biopharmaceutical processing
When it comes time to outsource the manufacturing of your product, you will have to decide which Contract Manufacturing Organisation...
12 December 2022
Case Study – Symbiosis and The Cell and Gene Therapy Catapult (CGT Catapult)
The manufacture of gene therapy viral vectors (tools used to deliver genetic material into cells) requires specialised, high-quality manufacturing facilities...
12 December 2022
Low Volume Fill Technical Case Study
Low volume aseptic filling of parenterals is becoming increasingly important with the development of more and more intravitreal drugs and...
12 December 2022
An Overview of the Qualified Persons’ (QP) Role in the Release of Batches of Biological Medicinal Products – Technical Note
The Qualified Person, frequently shortened to “QP” in guidance documents, plays a unique regulatory mandated role within both the UK...
28 October 2022
Biosafety level considerations in biologic manufacturing and aseptic filling of ATMPs – Technical Note
With the continued development and clinical availability of advanced therapeutic medicinal products (ATMPs), clinical and commercial manufacturers have had to...
28 October 2022
Aseptic Manufacturing Specialists – Brochure
Symbiosis values time as much as you do. With rapid access to manufacturing slots, and extensive expertise and experience across...